Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | CHEK2 |
Variant | F169L |
Impact List | missense |
Protein Effect | loss of function - predicted |
Gene Variant Descriptions | CHEK2 F169L lies within the FHA domain of the Chek2 protein (UniProt.org). F169L results in reduced Kap1 phosphorylation at serine (S)-473 upon ionizing radiation in cell culture (PMID: 34903604), and therefore, is predicted to lead to a loss of Chek2 protein function. |
Associated Drug Resistance | |
Category Variants Paths |
CHEK2 mutant CHEK2 inact mut CHEK2 F169L |
Transcript | NM_007194.4 |
gDNA | chr22:g.28725064A>G |
cDNA | c.505T>C |
Protein | p.F169L |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_007194.4 | chr22:g.28725064A>G | c.505T>C | p.F169L | RefSeq | GRCh38/hg38 |
NM_145862.2 | chr22:g.28725064A>G | c.505T>C | p.F169L | RefSeq | GRCh38/hg38 |
NM_007194.3 | chr22:g.28725064A>G | c.505T>C | p.F169L | RefSeq | GRCh38/hg38 |
NM_145862.2 | chr22:g.28725064A>G | c.505T>C | p.F169L | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|